BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 24607832)

  • 21. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration.
    Hébert SS; Papadopoulou AS; Smith P; Galas MC; Planel E; Silahtaroglu AN; Sergeant N; Buée L; De Strooper B
    Hum Mol Genet; 2010 Oct; 19(20):3959-69. PubMed ID: 20660113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.
    Thum T; Condorelli G
    Circ Res; 2015 Feb; 116(4):751-62. PubMed ID: 25677521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studying the differential co-expression of microRNAs reveals significant role of white matter in early Alzheimer's progression.
    Bhattacharyya M; Bandyopadhyay S
    Mol Biosyst; 2013 Mar; 9(3):457-66. PubMed ID: 23344858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Emerging Role of Long Non-Coding RNAs and MicroRNAs in Neurodegenerative Diseases: A Perspective of Machine Learning.
    García-Fonseca Á; Martin-Jimenez C; Barreto GE; Pachón AFA; González J
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in Alzheimer's disease.
    Delay C; Mandemakers W; Hébert SS
    Neurobiol Dis; 2012 May; 46(2):285-90. PubMed ID: 22285895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease.
    Yoon H; Flores LF; Kim J
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt B):2139-2147. PubMed ID: 27155217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology.
    Stygelbout V; Leroy K; Pouillon V; Ando K; D'Amico E; Jia Y; Luo HR; Duyckaerts C; Erneux C; Schurmans S; Brion JP
    Brain; 2014 Feb; 137(Pt 2):537-52. PubMed ID: 24401760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.
    Salta E; De Strooper B
    FASEB J; 2017 Feb; 31(2):424-433. PubMed ID: 28148775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgens and Alzheimer's disease.
    Drummond ES; Harvey AR; Martins RN
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):254-9. PubMed ID: 19373081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tau, amyloid and Alzheimer's disease].
    Olesen OF
    Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory non-coding transcripts in spermatogenesis: shedding light on 'dark matter'.
    Mukherjee A; Koli S; Reddy KV
    Andrology; 2014 May; 2(3):360-9. PubMed ID: 24519965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.
    Han Y; Liu Y; Zhang H; Wang T; Diao R; Jiang Z; Gui Y; Cai Z
    FEBS Lett; 2013 Nov; 587(23):3875-82. PubMed ID: 24396870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
    Porzoor A; Macreadie IG
    J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
    Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
    Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances with Long Non-Coding RNAs in Alzheimer's Disease as Peripheral Biomarker.
    Garofalo M; Pandini C; Sproviero D; Pansarasa O; Cereda C; Gagliardi S
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
    J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research status of the regulation of miRNA on BACE1.
    Deng Y; Ding Y; Hou D
    Int J Neurosci; 2014 Jul; 124(7):474-7. PubMed ID: 24147552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sources of extracellular tau and its signaling.
    Avila J; Simón D; Díaz-Hernández M; Pintor J; Hernández F
    J Alzheimers Dis; 2014; 40 Suppl 1():S7-S15. PubMed ID: 24531154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.